Hector Gonzalez, MD
Gastroenterology · Plantation, FLNPI 1629500129
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (59.4%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Sanofi accounts for 69.5% of it on its own, with 19 other manufacturers making up the rest. 2025 is the largest year on record at $10,170, more than ten times the $52 reported in 2020.
Across 170 payments — averaging $71.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$8K
- Johnson & Johnson$883
- AbbVie$776
- Intercept Pharmaceuticals, Inc.$355
- Madrigal Pharmaceuticals$299
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$284
- plus $1K from 14 others
What the payments were for
- Consulting fees$7,20059%
- Travel & lodging$5525%
- Food & beverage$4,17834%
- Education$1922%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 17 | $8,423 |
| Johnson & Johnson | 32 | $883 |
| AbbVie | 41 | $776 |
| Intercept Pharmaceuticals, Inc. | 7 | $355 |
| Madrigal Pharmaceuticals | 6 | $299 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 14 | $284 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $239 |
| Ardelyx, Inc. | 7 | $155 |
| Phathom Pharmaceuticals, Inc. | 8 | $148 |
| Bristol Myers Squibb | 8 | $145 |
| Lilly USA, LLC | 5 | $108 |
| Pfizer | 4 | $77 |
| Aimmune Therapeutics, Inc. | 3 | $66 |
| Merck | 2 | $41 |
| Novo Nordisk | 1 | $32 |
| Mallinckrodt Hospital Products Inc. | 1 | $31 |
| Redhill Biopharma Inc. | 1 | $23 |
| Gilead | 1 | $17 |
| Evoke Pharma, Inc. | 1 | $16 |
| Micro-tech Endoscopy USA, Inc. | 1 | $5 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$12,123 in reported general payments places this provider in the 85th percentile of 1,388 gastroenterology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClenpiqSod Picosulf/Mag Ox/Citric Ac | 56 | $9,362 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 37 | $2,585 |
| Pantoprazole Sodium | 79 | $403 |
| Omeprazole | 13 | $93 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Plantation
- Samuel GidayOrlando$2M
- Lukasz KwapiszMiami$1.2M
- Jennifer Seminerio-DiehlOrlando$1.1M
- Udayakumar NavaneethanSaint Petersburg$1.1M
- Ronen AraiCoral Springs$1.1M
- Charles SninskyGainesville$983K
- Peter DraganovGainesville$832K
- Arin NewmanMiami Beach$716K
- Joanna LopezMiami$670K
- Jose NietoSebring$573K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.